ISCO — International Stem Cell CORP
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1355790 ·
Last close
$0.35
Market Cap
$2.80M
52W High
$0.54
52W Low
$0.12
ADV30
44,077
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 2,675,000 | 1,458,000 | -35,000 | -71,000 | 5,056,000 | 1,089,000 | 9,284,000 |
| Mar 2026 | 2,315,000 | 1,361,000 | -190,000 | -220,000 | 5,133,000 | 933,000 | 9,349,000 |
| Dec 2025 | 2,155,000 | 1,089,000 | -313,000 | -348,000 | 4,819,000 | 993,000 | 8,879,000 |
| Sep 2025 | 2,369,000 | 1,321,000 | 94,000 | 57,000 | 5,282,000 | 966,000 | 9,058,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-98,000
Investing CF
$-71,000
Financing CF
$-150,000
CapEx
$-71,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.05
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-111,323,000
Inventory
$1,773,000
Receivables
$843,000
ST Investments
—
EBIT TTM
$-237,000
Pretax Income TTM
$-382,000
Interest Exp TTM
$145,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,514,000
EBITDA
$-162,000
Free Cash Flow
$394,750
Enterprise Value
$9,512,558
Total Cash
$1,089,000
Total Debt
$3,455,000
Shares Out
8,004,389
Trailing EPS
$-0.07
Book Value
$-0.53
ROE
-244.5%
ROA
-3.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,100,000 | -267,000 | -418,000 | 4,819,000 | 8,879,000 | -4,060,000 | 8,000 |
| Dec 2024 | 9,085,000 | -68,000 | -209,000 | 5,173,000 | 9,103,000 | -3,930,000 | 13,000 |
| Dec 2023 | 7,789,000 | -663,000 | -131,000 | 5,390,000 | 9,577,000 | -4,187,000 | 929,000 |
| Dec 2022 | 8,180,000 | -183,000 | -331,000 | 5,135,000 | 9,655,000 | -4,520,000 | 332,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.88
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TCRT | Alaunos Therapeutics, Inc. | $2.77M | $1.09 | — |
| GNPX | Genprex, Inc. | $2.70M | $3.29 | — |
| VBIO | Valion Bio, Inc. | $2.69M | $3.03 | — |
| CASIF | CASI Pharmaceuticals, Inc. | $2.67M | $0.13 | — |
| VCNX | VACCINEX, INC. | $2.60M | $0.97 | — |
Recent Insider Activity
No insider activity indexed for this ticker.